Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain
RecruitingNot applicableNCT07241559
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study is to investigate the effects of thoracolumbar fascia mobilization and ultrasound-guided thoracolumbar interfascial 5% dextrose injection on pain, range of motion, disability, quality of life, proprioception, and fascial thickness and echogenicity in patients with nonspecific chronic low back pain. -Primary Objective: The primary objective is to evaluate the effects of these interventions on pain, functional status and range of motion. -Secondary Objective: The secondary objective is to assess the long-term effects on quality of life, proprioception, fascial thickness, and echogenicity.
Study details
- Official title
- Comparison of the Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided Thoracolumbar Interfascial 5% Dextrose Injection in Patients With Chronic Low Back Pain
- Conditions
- Interventions
- Drug: 5% dextrose injection
- Procedure: Myofascial Release
- Sponsor
- Ankara City Hospital Bilkent
- Collaborators
- Ankara Training and Research Hospital
- Start date
- 2025-11-01
- Primary completion
- 2026-04-01
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Male or female patients aged 18 to 65 years 2. Presence of low back pain lasting longer than 3 months 3. No adequate response to medical treatment 4. Voluntary participation in the study Exclusion Criteria: 1. Age below 18 or above 65 years 2. Body mass index (BMI) greater than 30 kg/m² 3. Pregnancy or breastfeeding 4. Presence of coagulation disorders 5. History of spinal surgery 6. Presence of inflammatory or malignant diseases 7. Local infection at the spine or injection site 8. Presence of lumbar disc pathology causing radiculopathy 9. Presence of spinal stenosis, spondylolysis, or spondylolisthesis 10. Participation in physical therapy or any manual therapy within the past 6 months 11. Receiving lumbar injections within the past 6 months 12. History of allergy to injection materials 13. Refusal to participate in the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07241559